Global Amphetamine Drug Market Research Report 2023
Amphetamine (alpha-methylphenethylamine) is a central nervous system (CNS) stimulant that affects the nervous system of the body targeting brain chemicals for hyperactivity and impulse control.
According to QYResearch’s new survey, global Amphetamine Drug market is projected to reach US$ 541.7 million in 2029, increasing from US$ 341 million in 2022, with the CAGR of 6.8% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Amphetamine Drug market research.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Amphetamine Drug market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
According to QYResearch’s new survey, global Amphetamine Drug market is projected to reach US$ 541.7 million in 2029, increasing from US$ 341 million in 2022, with the CAGR of 6.8% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Amphetamine Drug market research.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Amphetamine Drug market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
- Pfizer
- Novartis
- Eli Lilly
- GSK
- Hisamitsu Pharmaceutical
- Purdue Pharma
- Adult
- Children
- Retail Pharmacy
- Hospital Pharmacy
- Other
- North America
- United States
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- China Taiwan
- Indonesia
- Thailand
- Malaysia
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
1 AMPHETAMINE DRUG MARKET OVERVIEW
1.1 Product Overview and Scope of Amphetamine Drug
1.2 Amphetamine Drug Segment by Type
1.2.1 Global Amphetamine Drug Market Value Comparison by Type (2023-2029)
1.2.2 Adult
1.2.3 Children
1.3 Amphetamine Drug Segment by Application
1.3.1 Global Amphetamine Drug Market Value by Application: (2023-2029)
1.3.2 Retail Pharmacy
1.3.3 Hospital Pharmacy
1.3.4 Other
1.4 Global Amphetamine Drug Market Size Estimates and Forecasts
1.4.1 Global Amphetamine Drug Revenue 2018-2029
1.4.2 Global Amphetamine Drug Sales 2018-2029
1.4.3 Global Amphetamine Drug Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 AMPHETAMINE DRUG MARKET COMPETITION BY MANUFACTURERS
2.1 Global Amphetamine Drug Sales Market Share by Manufacturers (2018-2023)
2.2 Global Amphetamine Drug Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Amphetamine Drug Average Price by Manufacturers (2018-2023)
2.4 Global Amphetamine Drug Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Amphetamine Drug, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Amphetamine Drug, Product Type & Application
2.7 Amphetamine Drug Market Competitive Situation and Trends
2.7.1 Amphetamine Drug Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Amphetamine Drug Players Market Share by Revenue
2.7.3 Global Amphetamine Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 AMPHETAMINE DRUG RETROSPECTIVE MARKET SCENARIO BY REGION
3.1 Global Amphetamine Drug Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Amphetamine Drug Global Amphetamine Drug Sales by Region: 2018-2029
3.2.1 Global Amphetamine Drug Sales by Region: 2018-2023
3.2.2 Global Amphetamine Drug Sales by Region: 2024-2029
3.3 Global Amphetamine Drug Global Amphetamine Drug Revenue by Region: 2018-2029
3.3.1 Global Amphetamine Drug Revenue by Region: 2018-2023
3.3.2 Global Amphetamine Drug Revenue by Region: 2024-2029
3.4 North America Amphetamine Drug Market Facts & Figures by Country
3.4.1 North America Amphetamine Drug Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Amphetamine Drug Sales by Country (2018-2029)
3.4.3 North America Amphetamine Drug Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Amphetamine Drug Market Facts & Figures by Country
3.5.1 Europe Amphetamine Drug Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Amphetamine Drug Sales by Country (2018-2029)
3.5.3 Europe Amphetamine Drug Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Amphetamine Drug Market Facts & Figures by Country
3.6.1 Asia Pacific Amphetamine Drug Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Amphetamine Drug Sales by Country (2018-2029)
3.6.3 Asia Pacific Amphetamine Drug Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Amphetamine Drug Market Facts & Figures by Country
3.7.1 Latin America Amphetamine Drug Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Amphetamine Drug Sales by Country (2018-2029)
3.7.3 Latin America Amphetamine Drug Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Amphetamine Drug Market Facts & Figures by Country
3.8.1 Middle East and Africa Amphetamine Drug Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Amphetamine Drug Sales by Country (2018-2029)
3.8.3 Middle East and Africa Amphetamine Drug Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 SEGMENT BY TYPE
4.1 Global Amphetamine Drug Sales by Type (2018-2029)
4.1.1 Global Amphetamine Drug Sales by Type (2018-2023)
4.1.2 Global Amphetamine Drug Sales by Type (2024-2029)
4.1.3 Global Amphetamine Drug Sales Market Share by Type (2018-2029)
4.2 Global Amphetamine Drug Revenue by Type (2018-2029)
4.2.1 Global Amphetamine Drug Revenue by Type (2018-2023)
4.2.2 Global Amphetamine Drug Revenue by Type (2024-2029)
4.2.3 Global Amphetamine Drug Revenue Market Share by Type (2018-2029)
4.3 Global Amphetamine Drug Price by Type (2018-2029)
5 SEGMENT BY APPLICATION
5.1 Global Amphetamine Drug Sales by Application (2018-2029)
5.1.1 Global Amphetamine Drug Sales by Application (2018-2023)
5.1.2 Global Amphetamine Drug Sales by Application (2024-2029)
5.1.3 Global Amphetamine Drug Sales Market Share by Application (2018-2029)
5.2 Global Amphetamine Drug Revenue by Application (2018-2029)
5.2.1 Global Amphetamine Drug Revenue by Application (2018-2023)
5.2.2 Global Amphetamine Drug Revenue by Application (2024-2029)
5.2.3 Global Amphetamine Drug Revenue Market Share by Application (2018-2029)
5.3 Global Amphetamine Drug Price by Application (2018-2029)
6 KEY COMPANIES PROFILED
6.1 Pfizer
6.1.1 Pfizer Corporation Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer Amphetamine Drug Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Pfizer Amphetamine Drug Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 Novartis
6.2.1 Novartis Corporation Information
6.2.2 Novartis Description and Business Overview
6.2.3 Novartis Amphetamine Drug Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Novartis Amphetamine Drug Product Portfolio
6.2.5 Novartis Recent Developments/Updates
6.3 Eli Lilly
6.3.1 Eli Lilly Corporation Information
6.3.2 Eli Lilly Description and Business Overview
6.3.3 Eli Lilly Amphetamine Drug Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Eli Lilly Amphetamine Drug Product Portfolio
6.3.5 Eli Lilly Recent Developments/Updates
6.4 GSK
6.4.1 GSK Corporation Information
6.4.2 GSK Description and Business Overview
6.4.3 GSK Amphetamine Drug Sales, Revenue and Gross Margin (2018-2023)
6.4.4 GSK Amphetamine Drug Product Portfolio
6.4.5 GSK Recent Developments/Updates
6.5 Hisamitsu Pharmaceutical
6.5.1 Hisamitsu Pharmaceutical Corporation Information
6.5.2 Hisamitsu Pharmaceutical Description and Business Overview
6.5.3 Hisamitsu Pharmaceutical Amphetamine Drug Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Hisamitsu Pharmaceutical Amphetamine Drug Product Portfolio
6.5.5 Hisamitsu Pharmaceutical Recent Developments/Updates
6.6 Purdue Pharma
6.6.1 Purdue Pharma Corporation Information
6.6.2 Purdue Pharma Description and Business Overview
6.6.3 Purdue Pharma Amphetamine Drug Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Purdue Pharma Amphetamine Drug Product Portfolio
6.6.5 Purdue Pharma Recent Developments/Updates
7 INDUSTRY CHAIN AND SALES CHANNELS ANALYSIS
7.1 Amphetamine Drug Industry Chain Analysis
7.2 Amphetamine Drug Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Amphetamine Drug Production Mode & Process
7.4 Amphetamine Drug Sales and Marketing
7.4.1 Amphetamine Drug Sales Channels
7.4.2 Amphetamine Drug Distributors
7.5 Amphetamine Drug Customers
8 AMPHETAMINE DRUG MARKET DYNAMICS
8.1 Amphetamine Drug Industry Trends
8.2 Amphetamine Drug Market Drivers
8.3 Amphetamine Drug Market Challenges
8.4 Amphetamine Drug Market Restraints
9 RESEARCH FINDING AND CONCLUSION
10 METHODOLOGY AND DATA SOURCE
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Overview and Scope of Amphetamine Drug
1.2 Amphetamine Drug Segment by Type
1.2.1 Global Amphetamine Drug Market Value Comparison by Type (2023-2029)
1.2.2 Adult
1.2.3 Children
1.3 Amphetamine Drug Segment by Application
1.3.1 Global Amphetamine Drug Market Value by Application: (2023-2029)
1.3.2 Retail Pharmacy
1.3.3 Hospital Pharmacy
1.3.4 Other
1.4 Global Amphetamine Drug Market Size Estimates and Forecasts
1.4.1 Global Amphetamine Drug Revenue 2018-2029
1.4.2 Global Amphetamine Drug Sales 2018-2029
1.4.3 Global Amphetamine Drug Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 AMPHETAMINE DRUG MARKET COMPETITION BY MANUFACTURERS
2.1 Global Amphetamine Drug Sales Market Share by Manufacturers (2018-2023)
2.2 Global Amphetamine Drug Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Amphetamine Drug Average Price by Manufacturers (2018-2023)
2.4 Global Amphetamine Drug Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Amphetamine Drug, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Amphetamine Drug, Product Type & Application
2.7 Amphetamine Drug Market Competitive Situation and Trends
2.7.1 Amphetamine Drug Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Amphetamine Drug Players Market Share by Revenue
2.7.3 Global Amphetamine Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 AMPHETAMINE DRUG RETROSPECTIVE MARKET SCENARIO BY REGION
3.1 Global Amphetamine Drug Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Amphetamine Drug Global Amphetamine Drug Sales by Region: 2018-2029
3.2.1 Global Amphetamine Drug Sales by Region: 2018-2023
3.2.2 Global Amphetamine Drug Sales by Region: 2024-2029
3.3 Global Amphetamine Drug Global Amphetamine Drug Revenue by Region: 2018-2029
3.3.1 Global Amphetamine Drug Revenue by Region: 2018-2023
3.3.2 Global Amphetamine Drug Revenue by Region: 2024-2029
3.4 North America Amphetamine Drug Market Facts & Figures by Country
3.4.1 North America Amphetamine Drug Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Amphetamine Drug Sales by Country (2018-2029)
3.4.3 North America Amphetamine Drug Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Amphetamine Drug Market Facts & Figures by Country
3.5.1 Europe Amphetamine Drug Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Amphetamine Drug Sales by Country (2018-2029)
3.5.3 Europe Amphetamine Drug Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Amphetamine Drug Market Facts & Figures by Country
3.6.1 Asia Pacific Amphetamine Drug Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Amphetamine Drug Sales by Country (2018-2029)
3.6.3 Asia Pacific Amphetamine Drug Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Amphetamine Drug Market Facts & Figures by Country
3.7.1 Latin America Amphetamine Drug Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Amphetamine Drug Sales by Country (2018-2029)
3.7.3 Latin America Amphetamine Drug Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Amphetamine Drug Market Facts & Figures by Country
3.8.1 Middle East and Africa Amphetamine Drug Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Amphetamine Drug Sales by Country (2018-2029)
3.8.3 Middle East and Africa Amphetamine Drug Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 SEGMENT BY TYPE
4.1 Global Amphetamine Drug Sales by Type (2018-2029)
4.1.1 Global Amphetamine Drug Sales by Type (2018-2023)
4.1.2 Global Amphetamine Drug Sales by Type (2024-2029)
4.1.3 Global Amphetamine Drug Sales Market Share by Type (2018-2029)
4.2 Global Amphetamine Drug Revenue by Type (2018-2029)
4.2.1 Global Amphetamine Drug Revenue by Type (2018-2023)
4.2.2 Global Amphetamine Drug Revenue by Type (2024-2029)
4.2.3 Global Amphetamine Drug Revenue Market Share by Type (2018-2029)
4.3 Global Amphetamine Drug Price by Type (2018-2029)
5 SEGMENT BY APPLICATION
5.1 Global Amphetamine Drug Sales by Application (2018-2029)
5.1.1 Global Amphetamine Drug Sales by Application (2018-2023)
5.1.2 Global Amphetamine Drug Sales by Application (2024-2029)
5.1.3 Global Amphetamine Drug Sales Market Share by Application (2018-2029)
5.2 Global Amphetamine Drug Revenue by Application (2018-2029)
5.2.1 Global Amphetamine Drug Revenue by Application (2018-2023)
5.2.2 Global Amphetamine Drug Revenue by Application (2024-2029)
5.2.3 Global Amphetamine Drug Revenue Market Share by Application (2018-2029)
5.3 Global Amphetamine Drug Price by Application (2018-2029)
6 KEY COMPANIES PROFILED
6.1 Pfizer
6.1.1 Pfizer Corporation Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer Amphetamine Drug Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Pfizer Amphetamine Drug Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 Novartis
6.2.1 Novartis Corporation Information
6.2.2 Novartis Description and Business Overview
6.2.3 Novartis Amphetamine Drug Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Novartis Amphetamine Drug Product Portfolio
6.2.5 Novartis Recent Developments/Updates
6.3 Eli Lilly
6.3.1 Eli Lilly Corporation Information
6.3.2 Eli Lilly Description and Business Overview
6.3.3 Eli Lilly Amphetamine Drug Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Eli Lilly Amphetamine Drug Product Portfolio
6.3.5 Eli Lilly Recent Developments/Updates
6.4 GSK
6.4.1 GSK Corporation Information
6.4.2 GSK Description and Business Overview
6.4.3 GSK Amphetamine Drug Sales, Revenue and Gross Margin (2018-2023)
6.4.4 GSK Amphetamine Drug Product Portfolio
6.4.5 GSK Recent Developments/Updates
6.5 Hisamitsu Pharmaceutical
6.5.1 Hisamitsu Pharmaceutical Corporation Information
6.5.2 Hisamitsu Pharmaceutical Description and Business Overview
6.5.3 Hisamitsu Pharmaceutical Amphetamine Drug Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Hisamitsu Pharmaceutical Amphetamine Drug Product Portfolio
6.5.5 Hisamitsu Pharmaceutical Recent Developments/Updates
6.6 Purdue Pharma
6.6.1 Purdue Pharma Corporation Information
6.6.2 Purdue Pharma Description and Business Overview
6.6.3 Purdue Pharma Amphetamine Drug Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Purdue Pharma Amphetamine Drug Product Portfolio
6.6.5 Purdue Pharma Recent Developments/Updates
7 INDUSTRY CHAIN AND SALES CHANNELS ANALYSIS
7.1 Amphetamine Drug Industry Chain Analysis
7.2 Amphetamine Drug Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Amphetamine Drug Production Mode & Process
7.4 Amphetamine Drug Sales and Marketing
7.4.1 Amphetamine Drug Sales Channels
7.4.2 Amphetamine Drug Distributors
7.5 Amphetamine Drug Customers
8 AMPHETAMINE DRUG MARKET DYNAMICS
8.1 Amphetamine Drug Industry Trends
8.2 Amphetamine Drug Market Drivers
8.3 Amphetamine Drug Market Challenges
8.4 Amphetamine Drug Market Restraints
9 RESEARCH FINDING AND CONCLUSION
10 METHODOLOGY AND DATA SOURCE
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
LIST OF TABLES
Table 1. Global Amphetamine Drug Market Value Comparison by Type (2023-2029) & (US$ Million)
Table 2. Global Amphetamine Drug Market Value Comparison by Application (2023-2029) & (US$ Million)
Table 3. Global Amphetamine Drug Market Competitive Situation by Manufacturers in 2022
Table 4. Global Amphetamine Drug Sales (K Units) of Key Manufacturers (2018-2023)
Table 5. Global Amphetamine Drug Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Amphetamine Drug Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Amphetamine Drug Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Amphetamine Drug Average Price (US$/Unit) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Amphetamine Drug, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of Amphetamine Drug, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Amphetamine Drug, Product Type & Application
Table 12. Global Key Manufacturers of Amphetamine Drug, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Amphetamine Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Amphetamine Drug as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Amphetamine Drug Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Amphetamine Drug Sales by Region (2018-2023) & (K Units)
Table 18. Global Amphetamine Drug Sales Market Share by Region (2018-2023)
Table 19. Global Amphetamine Drug Sales by Region (2024-2029) & (K Units)
Table 20. Global Amphetamine Drug Sales Market Share by Region (2024-2029)
Table 21. Global Amphetamine Drug Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Amphetamine Drug Revenue Market Share by Region (2018-2023)
Table 23. Global Amphetamine Drug Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Amphetamine Drug Revenue Market Share by Region (2024-2029)
Table 25. North America Amphetamine Drug Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Amphetamine Drug Sales by Country (2018-2023) & (K Units)
Table 27. North America Amphetamine Drug Sales by Country (2024-2029) & (K Units)
Table 28. North America Amphetamine Drug Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Amphetamine Drug Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Amphetamine Drug Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Amphetamine Drug Sales by Country (2018-2023) & (K Units)
Table 32. Europe Amphetamine Drug Sales by Country (2024-2029) & (K Units)
Table 33. Europe Amphetamine Drug Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Amphetamine Drug Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Amphetamine Drug Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Amphetamine Drug Sales by Region (2018-2023) & (K Units)
Table 37. Asia Pacific Amphetamine Drug Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific Amphetamine Drug Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Amphetamine Drug Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Amphetamine Drug Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Amphetamine Drug Sales by Country (2018-2023) & (K Units)
Table 42. Latin America Amphetamine Drug Sales by Country (2024-2029) & (K Units)
Table 43. Latin America Amphetamine Drug Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Amphetamine Drug Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Amphetamine Drug Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Amphetamine Drug Sales by Country (2018-2023) & (K Units)
Table 47. Middle East & Africa Amphetamine Drug Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa Amphetamine Drug Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Amphetamine Drug Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Amphetamine Drug Sales (K Units) by Type (2018-2023)
Table 51. Global Amphetamine Drug Sales (K Units) by Type (2024-2029)
Table 52. Global Amphetamine Drug Sales Market Share by Type (2018-2023)
Table 53. Global Amphetamine Drug Sales Market Share by Type (2024-2029)
Table 54. Global Amphetamine Drug Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Amphetamine Drug Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Amphetamine Drug Revenue Market Share by Type (2018-2023)
Table 57. Global Amphetamine Drug Revenue Market Share by Type (2024-2029)
Table 58. Global Amphetamine Drug Price (US$/Unit) by Type (2018-2023)
Table 59. Global Amphetamine Drug Price (US$/Unit) by Type (2024-2029)
Table 60. Global Amphetamine Drug Sales (K Units) by Application (2018-2023)
Table 61. Global Amphetamine Drug Sales (K Units) by Application (2024-2029)
Table 62. Global Amphetamine Drug Sales Market Share by Application (2018-2023)
Table 63. Global Amphetamine Drug Sales Market Share by Application (2024-2029)
Table 64. Global Amphetamine Drug Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Amphetamine Drug Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Amphetamine Drug Revenue Market Share by Application (2018-2023)
Table 67. Global Amphetamine Drug Revenue Market Share by Application (2024-2029)
Table 68. Global Amphetamine Drug Price (US$/Unit) by Application (2018-2023)
Table 69. Global Amphetamine Drug Price (US$/Unit) by Application (2024-2029)
Table 70. Pfizer Corporation Information
Table 71. Pfizer Description and Business Overview
Table 72. Pfizer Amphetamine Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 73. Pfizer Amphetamine Drug Product
Table 74. Pfizer Recent Developments/Updates
Table 75. Novartis Corporation Information
Table 76. Novartis Description and Business Overview
Table 77. Novartis Amphetamine Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 78. Novartis Amphetamine Drug Product
Table 79. Novartis Recent Developments/Updates
Table 80. Eli Lilly Corporation Information
Table 81. Eli Lilly Description and Business Overview
Table 82. Eli Lilly Amphetamine Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 83. Eli Lilly Amphetamine Drug Product
Table 84. Eli Lilly Recent Developments/Updates
Table 85. GSK Corporation Information
Table 86. GSK Description and Business Overview
Table 87. GSK Amphetamine Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 88. GSK Amphetamine Drug Product
Table 89. GSK Recent Developments/Updates
Table 90. Hisamitsu Pharmaceutical Corporation Information
Table 91. Hisamitsu Pharmaceutical Description and Business Overview
Table 92. Hisamitsu Pharmaceutical Amphetamine Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 93. Hisamitsu Pharmaceutical Amphetamine Drug Product
Table 94. Hisamitsu Pharmaceutical Recent Developments/Updates
Table 95. Purdue Pharma Corporation Information
Table 96. Purdue Pharma Description and Business Overview
Table 97. Purdue Pharma Amphetamine Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 98. Purdue Pharma Amphetamine Drug Product
Table 99. Purdue Pharma Recent Developments/Updates
Table 100. Key Raw Materials Lists
Table 101. Raw Materials Key Suppliers Lists
Table 102. Amphetamine Drug Distributors List
Table 103. Amphetamine Drug Customers List
Table 104. Amphetamine Drug Market Trends
Table 105. Amphetamine Drug Market Drivers
Table 106. Amphetamine Drug Market Challenges
Table 107. Amphetamine Drug Market Restraints
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources
Table 1. Global Amphetamine Drug Market Value Comparison by Type (2023-2029) & (US$ Million)
Table 2. Global Amphetamine Drug Market Value Comparison by Application (2023-2029) & (US$ Million)
Table 3. Global Amphetamine Drug Market Competitive Situation by Manufacturers in 2022
Table 4. Global Amphetamine Drug Sales (K Units) of Key Manufacturers (2018-2023)
Table 5. Global Amphetamine Drug Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Amphetamine Drug Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Amphetamine Drug Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Amphetamine Drug Average Price (US$/Unit) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Amphetamine Drug, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of Amphetamine Drug, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Amphetamine Drug, Product Type & Application
Table 12. Global Key Manufacturers of Amphetamine Drug, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Amphetamine Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Amphetamine Drug as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Amphetamine Drug Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Amphetamine Drug Sales by Region (2018-2023) & (K Units)
Table 18. Global Amphetamine Drug Sales Market Share by Region (2018-2023)
Table 19. Global Amphetamine Drug Sales by Region (2024-2029) & (K Units)
Table 20. Global Amphetamine Drug Sales Market Share by Region (2024-2029)
Table 21. Global Amphetamine Drug Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Amphetamine Drug Revenue Market Share by Region (2018-2023)
Table 23. Global Amphetamine Drug Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Amphetamine Drug Revenue Market Share by Region (2024-2029)
Table 25. North America Amphetamine Drug Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Amphetamine Drug Sales by Country (2018-2023) & (K Units)
Table 27. North America Amphetamine Drug Sales by Country (2024-2029) & (K Units)
Table 28. North America Amphetamine Drug Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Amphetamine Drug Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Amphetamine Drug Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Amphetamine Drug Sales by Country (2018-2023) & (K Units)
Table 32. Europe Amphetamine Drug Sales by Country (2024-2029) & (K Units)
Table 33. Europe Amphetamine Drug Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Amphetamine Drug Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Amphetamine Drug Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Amphetamine Drug Sales by Region (2018-2023) & (K Units)
Table 37. Asia Pacific Amphetamine Drug Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific Amphetamine Drug Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Amphetamine Drug Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Amphetamine Drug Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Amphetamine Drug Sales by Country (2018-2023) & (K Units)
Table 42. Latin America Amphetamine Drug Sales by Country (2024-2029) & (K Units)
Table 43. Latin America Amphetamine Drug Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Amphetamine Drug Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Amphetamine Drug Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Amphetamine Drug Sales by Country (2018-2023) & (K Units)
Table 47. Middle East & Africa Amphetamine Drug Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa Amphetamine Drug Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Amphetamine Drug Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Amphetamine Drug Sales (K Units) by Type (2018-2023)
Table 51. Global Amphetamine Drug Sales (K Units) by Type (2024-2029)
Table 52. Global Amphetamine Drug Sales Market Share by Type (2018-2023)
Table 53. Global Amphetamine Drug Sales Market Share by Type (2024-2029)
Table 54. Global Amphetamine Drug Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Amphetamine Drug Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Amphetamine Drug Revenue Market Share by Type (2018-2023)
Table 57. Global Amphetamine Drug Revenue Market Share by Type (2024-2029)
Table 58. Global Amphetamine Drug Price (US$/Unit) by Type (2018-2023)
Table 59. Global Amphetamine Drug Price (US$/Unit) by Type (2024-2029)
Table 60. Global Amphetamine Drug Sales (K Units) by Application (2018-2023)
Table 61. Global Amphetamine Drug Sales (K Units) by Application (2024-2029)
Table 62. Global Amphetamine Drug Sales Market Share by Application (2018-2023)
Table 63. Global Amphetamine Drug Sales Market Share by Application (2024-2029)
Table 64. Global Amphetamine Drug Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Amphetamine Drug Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Amphetamine Drug Revenue Market Share by Application (2018-2023)
Table 67. Global Amphetamine Drug Revenue Market Share by Application (2024-2029)
Table 68. Global Amphetamine Drug Price (US$/Unit) by Application (2018-2023)
Table 69. Global Amphetamine Drug Price (US$/Unit) by Application (2024-2029)
Table 70. Pfizer Corporation Information
Table 71. Pfizer Description and Business Overview
Table 72. Pfizer Amphetamine Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 73. Pfizer Amphetamine Drug Product
Table 74. Pfizer Recent Developments/Updates
Table 75. Novartis Corporation Information
Table 76. Novartis Description and Business Overview
Table 77. Novartis Amphetamine Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 78. Novartis Amphetamine Drug Product
Table 79. Novartis Recent Developments/Updates
Table 80. Eli Lilly Corporation Information
Table 81. Eli Lilly Description and Business Overview
Table 82. Eli Lilly Amphetamine Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 83. Eli Lilly Amphetamine Drug Product
Table 84. Eli Lilly Recent Developments/Updates
Table 85. GSK Corporation Information
Table 86. GSK Description and Business Overview
Table 87. GSK Amphetamine Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 88. GSK Amphetamine Drug Product
Table 89. GSK Recent Developments/Updates
Table 90. Hisamitsu Pharmaceutical Corporation Information
Table 91. Hisamitsu Pharmaceutical Description and Business Overview
Table 92. Hisamitsu Pharmaceutical Amphetamine Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 93. Hisamitsu Pharmaceutical Amphetamine Drug Product
Table 94. Hisamitsu Pharmaceutical Recent Developments/Updates
Table 95. Purdue Pharma Corporation Information
Table 96. Purdue Pharma Description and Business Overview
Table 97. Purdue Pharma Amphetamine Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 98. Purdue Pharma Amphetamine Drug Product
Table 99. Purdue Pharma Recent Developments/Updates
Table 100. Key Raw Materials Lists
Table 101. Raw Materials Key Suppliers Lists
Table 102. Amphetamine Drug Distributors List
Table 103. Amphetamine Drug Customers List
Table 104. Amphetamine Drug Market Trends
Table 105. Amphetamine Drug Market Drivers
Table 106. Amphetamine Drug Market Challenges
Table 107. Amphetamine Drug Market Restraints
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Product Picture of Amphetamine Drug
Figure 2. Global Amphetamine Drug Market Value Comparison by Type (2023-2029) & (US$ Million)
Figure 3. Global Amphetamine Drug Market Share by Type in 2022 & 2029
Figure 4. Adult Product Picture
Figure 5. Children Product Picture
Figure 6. Global Amphetamine Drug Market Value Comparison by Application (2023-2029) & (US$ Million)
Figure 7. Global Amphetamine Drug Market Share by Application in 2022 & 2029
Figure 8. Retail Pharmacy
Figure 9. Hospital Pharmacy
Figure 10. Other
Figure 11. Global Amphetamine Drug Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 12. Global Amphetamine Drug Market Size (2018-2029) & (US$ Million)
Figure 13. Global Amphetamine Drug Sales (2018-2029) & (K Units)
Figure 14. Global Amphetamine Drug Average Price (US$/Unit) & (2018-2029)
Figure 15. Amphetamine Drug Report Years Considered
Figure 16. Amphetamine Drug Sales Share by Manufacturers in 2022
Figure 17. Global Amphetamine Drug Revenue Share by Manufacturers in 2022
Figure 18. The Global 5 and 10 Largest Amphetamine Drug Players: Market Share by Revenue in 2022
Figure 19. Amphetamine Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 20. Global Amphetamine Drug Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 21. North America Amphetamine Drug Sales Market Share by Country (2018-2029)
Figure 22. North America Amphetamine Drug Revenue Market Share by Country (2018-2029)
Figure 23. United States Amphetamine Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 24. Canada Amphetamine Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 25. Europe Amphetamine Drug Sales Market Share by Country (2018-2029)
Figure 26. Europe Amphetamine Drug Revenue Market Share by Country (2018-2029)
Figure 27. Germany Amphetamine Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 28. France Amphetamine Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. U.K. Amphetamine Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. Italy Amphetamine Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Russia Amphetamine Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Asia Pacific Amphetamine Drug Sales Market Share by Region (2018-2029)
Figure 33. Asia Pacific Amphetamine Drug Revenue Market Share by Region (2018-2029)
Figure 34. China Amphetamine Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. Japan Amphetamine Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. South Korea Amphetamine Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. India Amphetamine Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. Australia Amphetamine Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. China Taiwan Amphetamine Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Indonesia Amphetamine Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Thailand Amphetamine Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Malaysia Amphetamine Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Latin America Amphetamine Drug Sales Market Share by Country (2018-2029)
Figure 44. Latin America Amphetamine Drug Revenue Market Share by Country (2018-2029)
Figure 45. Mexico Amphetamine Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Brazil Amphetamine Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Argentina Amphetamine Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Middle East & Africa Amphetamine Drug Sales Market Share by Country (2018-2029)
Figure 49. Middle East & Africa Amphetamine Drug Revenue Market Share by Country (2018-2029)
Figure 50. Turkey Amphetamine Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. Saudi Arabia Amphetamine Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. UAE Amphetamine Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. Global Sales Market Share of Amphetamine Drug by Type (2018-2029)
Figure 54. Global Revenue Market Share of Amphetamine Drug by Type (2018-2029)
Figure 55. Global Amphetamine Drug Price (US$/Unit) by Type (2018-2029)
Figure 56. Global Sales Market Share of Amphetamine Drug by Application (2018-2029)
Figure 57. Global Revenue Market Share of Amphetamine Drug by Application (2018-2029)
Figure 58. Global Amphetamine Drug Price (US$/Unit) by Application (2018-2029)
Figure 59. Amphetamine Drug Value Chain
Figure 60. Amphetamine Drug Production Process
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Distributors Profiles
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Figure 1. Product Picture of Amphetamine Drug
Figure 2. Global Amphetamine Drug Market Value Comparison by Type (2023-2029) & (US$ Million)
Figure 3. Global Amphetamine Drug Market Share by Type in 2022 & 2029
Figure 4. Adult Product Picture
Figure 5. Children Product Picture
Figure 6. Global Amphetamine Drug Market Value Comparison by Application (2023-2029) & (US$ Million)
Figure 7. Global Amphetamine Drug Market Share by Application in 2022 & 2029
Figure 8. Retail Pharmacy
Figure 9. Hospital Pharmacy
Figure 10. Other
Figure 11. Global Amphetamine Drug Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 12. Global Amphetamine Drug Market Size (2018-2029) & (US$ Million)
Figure 13. Global Amphetamine Drug Sales (2018-2029) & (K Units)
Figure 14. Global Amphetamine Drug Average Price (US$/Unit) & (2018-2029)
Figure 15. Amphetamine Drug Report Years Considered
Figure 16. Amphetamine Drug Sales Share by Manufacturers in 2022
Figure 17. Global Amphetamine Drug Revenue Share by Manufacturers in 2022
Figure 18. The Global 5 and 10 Largest Amphetamine Drug Players: Market Share by Revenue in 2022
Figure 19. Amphetamine Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 20. Global Amphetamine Drug Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 21. North America Amphetamine Drug Sales Market Share by Country (2018-2029)
Figure 22. North America Amphetamine Drug Revenue Market Share by Country (2018-2029)
Figure 23. United States Amphetamine Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 24. Canada Amphetamine Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 25. Europe Amphetamine Drug Sales Market Share by Country (2018-2029)
Figure 26. Europe Amphetamine Drug Revenue Market Share by Country (2018-2029)
Figure 27. Germany Amphetamine Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 28. France Amphetamine Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. U.K. Amphetamine Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. Italy Amphetamine Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Russia Amphetamine Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Asia Pacific Amphetamine Drug Sales Market Share by Region (2018-2029)
Figure 33. Asia Pacific Amphetamine Drug Revenue Market Share by Region (2018-2029)
Figure 34. China Amphetamine Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. Japan Amphetamine Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. South Korea Amphetamine Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. India Amphetamine Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. Australia Amphetamine Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. China Taiwan Amphetamine Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Indonesia Amphetamine Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Thailand Amphetamine Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Malaysia Amphetamine Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Latin America Amphetamine Drug Sales Market Share by Country (2018-2029)
Figure 44. Latin America Amphetamine Drug Revenue Market Share by Country (2018-2029)
Figure 45. Mexico Amphetamine Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Brazil Amphetamine Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Argentina Amphetamine Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Middle East & Africa Amphetamine Drug Sales Market Share by Country (2018-2029)
Figure 49. Middle East & Africa Amphetamine Drug Revenue Market Share by Country (2018-2029)
Figure 50. Turkey Amphetamine Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. Saudi Arabia Amphetamine Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. UAE Amphetamine Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. Global Sales Market Share of Amphetamine Drug by Type (2018-2029)
Figure 54. Global Revenue Market Share of Amphetamine Drug by Type (2018-2029)
Figure 55. Global Amphetamine Drug Price (US$/Unit) by Type (2018-2029)
Figure 56. Global Sales Market Share of Amphetamine Drug by Application (2018-2029)
Figure 57. Global Revenue Market Share of Amphetamine Drug by Application (2018-2029)
Figure 58. Global Amphetamine Drug Price (US$/Unit) by Application (2018-2029)
Figure 59. Amphetamine Drug Value Chain
Figure 60. Amphetamine Drug Production Process
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Distributors Profiles
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
